Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Onconetix (ONCO) Invested Capital (2023 - 2025)

Onconetix (ONCO) has disclosed Invested Capital for 2 consecutive years, with $41.1 million as the latest value for Q3 2024.

  • On a quarterly basis, Invested Capital rose 301.56% to $41.1 million in Q3 2024 year-over-year; TTM through Sep 2024 was $41.1 million, a 301.56% increase, with the full-year FY2023 number at $1.4 million, changed N/A from a year prior.
  • Invested Capital was $41.1 million for Q3 2024 at Onconetix, up from -$28.7 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $41.1 million in Q3 2024 to a low of -$28.7 million in Q2 2024.